No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Clinical Trials as Topic
-
Disease Progression
-
Disease-Free Survival
-
Drug Eruptions / classification
-
Drug Eruptions / etiology*
-
Drug Eruptions / therapy
-
Enzyme Inhibitors / adverse effects
-
ErbB Receptors / antagonists & inhibitors*
-
Humans
-
Neoplasms / drug therapy*
-
Phosphotransferases / antagonists & inhibitors
-
Telangiectasis / chemically induced
-
Terminology as Topic
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Phosphotransferases
-
ErbB Receptors